Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction

US Patent 6764681 · Granted Jul 20, 2004

Assignee

Inventors

View full patent text on Google Patents →